NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,686 | -98.7% | 21,962 | -89.5% | 0.00% | -99.1% |
| Q1 2021 | $27,654,000 | -12.2% | 209,211 | +14.9% | 0.21% | -22.8% |
| Q4 2020 | $31,494,000 | +271.7% | 182,002 | +139.1% | 0.28% | +213.6% |
| Q3 2020 | $8,472,000 | +65.9% | 76,110 | -11.6% | 0.09% | +60.0% |
| Q2 2020 | $5,106,000 | +55.2% | 86,100 | +76.2% | 0.06% | +31.0% |
| Q1 2020 | $3,290,000 | -21.7% | 48,855 | -2.1% | 0.04% | +2.4% |
| Q4 2019 | $4,204,000 | -34.9% | 49,890 | -42.2% | 0.04% | -48.1% |
| Q3 2019 | $6,456,000 | -3.3% | 86,333 | -18.3% | 0.08% | -14.1% |
| Q2 2019 | $6,679,000 | +31.5% | 105,623 | +0.2% | 0.09% | +26.0% |
| Q1 2019 | $5,079,000 | +73.5% | 105,433 | +20.5% | 0.07% | +43.1% |
| Q4 2018 | $2,928,000 | -32.8% | 87,463 | +5.3% | 0.05% | -17.7% |
| Q3 2018 | $4,354,000 | +261.0% | 83,099 | +115.7% | 0.06% | +226.3% |
| Q2 2018 | $1,206,000 | – | 38,530 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |